GCMS choice of derivatization agent and drying agent
Posted: Thu Nov 03, 2011 1:01 am
My laboratory is using a GCMS method for toxicological general unknown screening in urine. The method uses BSTFA +1%TMCS to derivatize the sample. I have a basic question about the choice of derivatizing agent. What is the benefit of using BSTFA +1%TMCS in general unknown screening in comparison with other TMS or other types of derivatizing agents such as MTBSTFA, etc? Do commercial libraries such as NIST, wiley, PWM cover more TMS derivatized compounds than other types of derivatized compound?
From time to time, we have some drop in response of TMS derivatized analytes problem. The sample prep steps are as follows:
Toxi-tube A extraction
Transfer and dry organic extract.
Reconstitute with ethyl acetate for sample dilution.
Dry. 75deg C, 5min.
Add BSTFA +1%TMCS. 75 deg C 15min.
Ready for injection.
The ethyl acetate is HPLC grade and is dispensed directly from its container. I don't know if it is the culprit and if it needs to be further dehydrated before use? What dehydrating agent is suitable that will not interfere with GCMS system?
Any comments are appreciated. Thanks a lot!
From time to time, we have some drop in response of TMS derivatized analytes problem. The sample prep steps are as follows:
Toxi-tube A extraction
Transfer and dry organic extract.
Reconstitute with ethyl acetate for sample dilution.
Dry. 75deg C, 5min.
Add BSTFA +1%TMCS. 75 deg C 15min.
Ready for injection.
The ethyl acetate is HPLC grade and is dispensed directly from its container. I don't know if it is the culprit and if it needs to be further dehydrated before use? What dehydrating agent is suitable that will not interfere with GCMS system?
Any comments are appreciated. Thanks a lot!